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Abstract
Modeling the local absorption and retention patterns of membrane-permeant small molecules in a cellular context could
facilitate development of site-directed chemical agents for bioimaging or therapeutic applications. Here, we present an
integrative approach to this problem, combining in silico computational models, in vitro cell based assays and in vivo
biodistribution studies. To target small molecule probes to the epithelial cells of the upper airways, a multiscale
computational model of the lung was first used as a screening tool, in silico. Following virtual screening, cell monolayers
differentiated on microfabricated pore arrays and multilayer cultures of primary human bronchial epithelial cells
differentiated in an air-liquid interface were used to test the local absorption and intracellular retention patterns of selected
probes, in vitro. Lastly, experiments involving visualization of bioimaging probe distribution in the lungs after local and
systemic administration were used to test the relevance of computational models and cell-based assays, in vivo. The results
of in vivo experiments were consistent with the results of in silico simulations, indicating that mitochondrial accumulation of
membrane permeant, hydrophilic cations can be used to maximize local exposure and retention, specifically in the upper
airways after intratracheal administration.
Citation: Yu J-y, Zheng N, Mane G, Min KA, Hinestroza JP, et al. (2012) A Cell-based Computational Modeling Approach for Developing Site-Directed Molecular
Probes. PLoS Comput Biol 8(2): e1002378. doi:10.1371/journal.pcbi.1002378
Editor: Feilim Mac Gabhann, Johns Hopkins University, United States of America
Received September 19, 2011; Accepted December 20, 2011; Published February 23, 2012
Copyright:  2012 Yu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by funding from the National Institute of General Medical Sciences (grant RO1GM078200 to GRR) and the National Institute of
Child Health and Human Development (grant R15 HD065594 to KAS). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: grosania@umich.edu
. These authors equally contributed to this work.
Introduction
Local administration of therapeutic agents or bioimaging probes
is commonly used to maximize concentrations at a desired site of
action and to minimize side effects or background signals
associated with distribution in off-target sites. However, in the
specific case of inhaled, small molecule therapeutic agents or
bioimaging probes, cell impermeant molecules may rapidly
disappear from the sites of deposition via mucociliary clearance
[1,2]. Conversely, cell- permeant small molecules can rapidly
diffuse away and disappear from the site absorption, down their
concentration gradient [3]. Therefore, we decided to explore an
integrative simulation approach (Figure 1) to study how the
physicochemical properties of small molecule probes may be
optimized to maximize local targeting and retention in the upper
respiratory tract.
Previously, we constructed multiscale, cell-based computational
models of airways and alveoli to predict the relative absorption,
accumulation and retention of inhaled chemical agents [4]. In
these models, the transport of small molecules from the airway
surface lining to the blood or from the blood to the airway surface
lining were modeled using ordinary differential equations (ODEs)
[5,6]. These ODEs described the transport of drug molecules
across a series of cellular compartments bounded by lipid bilayers
(Figure 1A,), which form the surface of each airway generation,
modeled as a tube (Figure 1B). For a monoprotic base, the
concentration of molecule in each subcellular compartment was
divided into two components: neutral and ionized [7,8].
Accordingly, two drug specific properties were used as input to
simulate the transport process across each lipid bilayer: the
logarithms of the octanol:water partition coefficient of the neutral
form of the molecule (i.e., logPn) and the pKa of the molecule. The
logarithm of the octanol:water partition coefficient of the ionized
form of the molecule (i.e., logPd) can be derived from logPn or it
can be incorporated as an independent input parameter that can
be measured or calculated with cheminformatics software. For
different compartments with different pHs and lipid fractions, the
free fraction of the neutral and ionized forms of molecules was
calculated according to the molecule’s pKa, logPn, and logPd, using
the Henderson-Hasselback equation and the laws of mass action.
Anatomically, the structure of the airways was modeled as a
tree-like branching system of cylinders with progressively narrow-
ing diameter [9] (Figure 1C). Starting with the trachea as the trunk
of the tree and ending in the alveoli as the leaves, each branching
segment corresponded to an airway ‘generation’ characterized by
a particular surface area, blood flow, and cellular organization
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modeled as multiple layers of epithelial, interstitial and endothelial
cells separating the air from the blood. Several structural and
functional differences between the airways and alveoli are
noteworthy: 1) cartilage and smooth muscle are present only in
the interstitium of the airways; 2) the surface area of the alveoli is
two orders of magnitude larger than airways; and 3) while the
blood flow to the alveoli corresponds to 100% of cardiac output
from the right ventricle, the blood flow of the airways is
approximately 1% of the cardiac output from the left ventricle
[11,12].
To predict a molecule’s absorption and retention in each airway
generation, the transport properties of small molecules across
cellular membranes, as well as the local partitioning of molecules
into lipid in different subcellular compartments can be calculated
with the Fick and Nernst-Planck equations to describe the
transport of the neutral and charged species of the molecule [4].
In simulations, combinations of logP and pKa spanning a range of
values were used as input to simulate the changes in concentration
of molecules of varying chemical structure, as they are absorbed
from the airway surface lining liquid into the blood or vice versa.
Here, we applied this cell-based transport model as a virtual
screening tool, to identify compounds with differential distribution
profiles in airways and alveoli, after intratracheal (IT) or
intravenous (IV) administration. In addition, two innovative in
vitro cell based assays were developed to assess the absorption and
retention of molecules across multiple layers of cells along the
lateral (Figure 1 D–F) and transversal planes of a cell monolayer
(Figure 1G)). Finally, in vivo microscopic bioimaging experiments
were performed to visualize the distribution of fluorescent probes
in the lung after either IT or IV administration (Figure 1H). The
results revealed that the mitochondrial sequestration of hydrophil-
ic, cell-permeant cations can provide an effective mechanism for
maximizing their local exposure and retention at a site of
absorption. Accordingly, mitochondriotropic cations may be
useful as fiduciary markers of local, inhaled drug deposition
patterns in the upper respiratory tract.
Methods
General methodology
All of the equations and default parameter values were based on
our published model [4]. The ODEs that describe this lung
pharmacokinetic (PK) model were solved numerically in a
MatlabH simulation environment (Version R2009b, The Math-
works Inc, Natick, MA). The ODE15S solver was used to address
the issue of the stiffness in ODEs, and the relative and absolute
error tolerance was set as 10
212 to minimize numerical errors. The
Matlab scripts used for virtual screening and simulation purposes
are provided, together with detailed instructions for running them,
in the Supplementary Materials (Text S1, S2, S3, S4, S5, S6). The
results of detailed parameter sensitivity analysis are also provided
in the Supplementary Materials (Text S7).
Virtual screening of small monobasic molecules targeting
the airways after IT instillation
For virtual screening, the airway and alveoli were linked to a
systemic pharmacokinetic model through their respective blood
compartments using a single compartment PK elimination model
(eq. 1) [13]:
Vb
dCb
dt
~{CbCL ð1Þ
Where Vb is the volume of the blood compartment; Cb is the
concentration in the blood; and CL is the clearance. The same
initial dose (1 mg/kg) was used as an input parameter to simulate
IT instillation experiments in the airways and alveoli, respectively.
For virtual screening, clearance in the systemic circulation was set
to zero. The logPn (22 to 4 with interval of 0.1 units) and the pKa
(5 to 14 with interval of 0.2 units) of monobasic compounds were
independently varied and used as input parameters, in all possible
combinations. For each set of physicochemical input parameters
(logPn and pKa) two important pharmacokinetic indexes were
calculated: 1) the percentage of mass deposited in the airways and
alveoli (relative to the total mass in whole lung); and, 2) the
concentration in the alveolar and airway regions, calculated as the
sum of the masses in all the compartments in said regions of the
lung divided by the sum of all the compartment volumes in that
region. The area under the tissue concentration curve (AUC) for
the airways and alveoli was calculated using the trapezoidal rule.
The AUC ratio of airways to alveoli after inhalation was calculated
by dividing the AUC of the airways by the AUC of the alveoli for
every combination of logPn and pKa that were used as input.
For comparison, simulations were also run to simulate an
intravenous (IV) bolus injection, with the initial concentration in
venous blood as calculated with eq. 2:
C0,vb~Dose=Vvb, ð2Þ
The volume of venous and artery blood was set to 13.6 and 6.8 ml,
respectively [13,14]. The concentration in the blood was fixed
(clearance set to 0) with the assumption of no significant plasma
protein binding and a drug concentration blood to plasma ratio of
1.
Detailed simulation analysis of fluorescent probe
distribution in the airways and alveoli after local and
systemic administration
Based on the results of virtual screening, two fluorescent probes
were selected for further testing: HoechstH 33342 (Hoe, Molecular
Probes, CA, USA) to represent a highly hydrophobic, weakly basic
molecule that can serve as a reference marker for a readily
absorbed probe with limited intracellular retention; and, Mito-
trackerH Red (MTR, Molecular Probes, CA, USA) to represent a
more hydrophilic cation that could serve as a candidate fiduciary
Author Summary
We have developed an integrative, cell-based modeling
approach to facilitate the design and discovery of chemical
agents directed to specific sites of action within a living
organism. Here, a computational, multiscale transport
model of the lung was adapted to enable virtual screening
of small molecules targeting the epithelial cells of the
upper airways. In turn, the transport behaviors of selected
candidate probes were evaluated to establish their degree
of retention at a site of absorption, using computational
simulations as well as two in vitro cell-based assay systems.
Lastly, bioimaging experiments were performed to exam-
ine candidate molecules’ distribution in the lungs of mice
after local and systemic administration. Based on compu-
tational simulations, the higher mitochondrial density per
unit absorption surface area is the key parameter
determining the higher retention of small molecule
hydrophilic cations in the upper airways, relative to
lipophilic weak bases, specifically after intratracheal
administration.
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MTR was modeled with a single, fixed positive charge and a
logPd=0.16. Hoe was modeled as a lipophilic, monobasic molecule
with a pKa=7.8 and a logPn=4.49 (calculated with ChemAxon,
www.chemaxon.com). These physicochemical properties were used
as input parameters to calculate the time dependent changes of the
probe concentrations in the airways and alveoli, respectively. For
simulations of IT instillation, the same initial concentration (1 mM)
of MTR and Hoe was assumed as the initial condition for the
airways and alveoli. The same initial dose used for IT instillation
was also used for IV administration. Blood clearance was fixed to 0
for simulations, unless otherwise noted.
Cell–based transport assays on microfabricated pore
arrays
A customized transwell insert system was constructed using a
polyester membrane with microfabricated pore arrays precisely
machined using a focused ion beam (Hitachi FB-200A) [15]
(Figure 1 E). These membranes support cell growth and the pores
Figure 1. General methodology of integrative, cell based transport modeling. A) For computational simulations at the cellular level, a
monobasic compound diffuses across a phospholipid bilayer and undergoes ionization and partition/binding in each compartment. The neutral form
of the monobasic molecule is indicated as [M], and the protonated, cationic form of the molecule is indicated as [MH
+]. B) For computational
simulations at the histological level, each airway generation is modeled as a tube lined by epithelial cells; as molecules are absorbed over time, the
drug concentration in the lumen decreases accompanied by an increase in drug concentration in the circulation C) For computational simulations at
the organ level, the lung is modeled as a branching tree, with airway generation modeled as a cylinder, from the trachea to the alveoli. D)
Experimental design of insert system with patterned pore arrays on membrane support for viewing lateral transport of fluorescent molecules along
the plane of a cell monolayer, away from a point source. E) Transmitted light image of a 565, 3 mm diameter pore array (20 mm spacing) on a
polyester membrane. F) Transmitted light image of an MDCK cell monolayer above a membrane support with 363, 3 mm diameter pore array (40 mm
spacing). Scale bar: 40 mm. G) 3D reconstruction of confocal images of the distribution of three fluorescent probes added to the uppermost surface of
NHBE cell multilayers grown on air-liquid interface cultures on porous membrane support. Each 3D plane is composed of the image with the
fluorescent channel; red (MTR), blue (Hoe), and green (LTG). H) Illustration of the tiling algorithm used to visualize and quantify the distribution of
Hoe and MTR in lung cryosections, after IT and IV coadministration of the probes.
doi:10.1371/journal.pcbi.1002378.g001
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on a cell monolayer (Figure 1F)). The pore arrays were comprised
of 3 mm diameter cylindrical pores, arranged 20 mm apart in a 5-
by-5 square array. Pores were also arranged 40, 80 and 160 mm
apart in 3-by-3 symmetrical arrays. The pores were individually
machined using a high brightness Ga liquid metal ion source
coupled with a double lens focusing system. The perforated
membranes were glued (Krazy GlueH) to the bottom of hollow
TranswellH holder (Costar 3462 or 3460), creating a permeable
support for cell growth (Figure 1D). The integrity of the insert
system was tested by adding 5 mM Trypan Blue (dissolved in
Hank’s balanced salt solution; HBSS) to the insert wells [15]. The
insert was considered intact if there was no evidence of Trypan
Blue leakage from the edge of the insert membrane. For assessing
lateral cell-cell transport, Madin-Darby canine kidney (MDCK)
cells were purchased from ATCC (CCL-34
TM) and grown (37uC,
5% CO2) in Dulbecco’s modified Eagle’s medium (DMEM, Gibco
11995) containing 10% FBS (Gibco 10082), 16 non-essential
amino acids (Gibco 11140) and 1% penicillin/streptomycin (Gibco
15140). MDCK cells were seeded on polyester membranes
containing the pore arrays at a density between 1610
5–2610
5
cells/cm
2 and were grown until a confluent cell monolayer formed
(Figure 1F). To evaluate the effect of pore arrays on cell monolayer
intactness, MDCK cells were washed and incubated in transport
buffer (HBSS buffer supplemented with 25 mM D-glucose,
pH 7.4) for 30 min followed by transepithelial electrical resistance
(TEER) measurement using Millipore MillicellH ERS. Cell
monolayers were used for experiments only if the background
subtracted TEER values were higher than 100 V?cm
2 and if the
cells covering the pore arrays appeared as an intact monolayer.
Measurement of lateral cell-to-cell transport and
retention using microfabricated pore arrays
To assess cell-to-cell transport along the plane of the monolayer
(Figure 1D–F), fluorescent dyes were added into the basolateral
compartment of the transwell system (at time 0). The dynamic
staining pattern in the cells was imaged (Nikon TE2000S
epifluorescence microscope equipped with a triple-pass DAPI/
FITC/TRITC filter set (Chroma Technology Corp. 86013v2)).
The 12-bit grayscale images were acquired using a CCD camera
(Roper Scientific, Tucson, AZ). For measurements, individual cells
or nuclei in these images were manually outlined using the region
tool in MetaMorphH software (Molecular Devices Corporation,
Sunnyvale, CA). The average and standard deviation of cellular or
nucleus fluorescence intensity was measured using MetaMorphH,
after subtracting the background fluorescence intensity estimated
from the unstained regions of the monolayer distant to the pores.
The rate of Hoe staining in the nucleus was measured as the slope
of fluorescence increase normalized by the slope of increase in the
first nucleus (closest to the pore).
Measurement of intracellular retention using Normal
Human Bronchial Epithelial cell multilayers differentiated
on air-liquid interfaces
Normal human bronchial epithelial (NHBE) cells (Clonetics
TM,
passage 1; Lonza, Walkersville, MD) were cultured (37uC, 5%
CO2) and seeded (passage 2) at 2.5610
5 cells/cm
2 on a
TranswellH insert (Corning Inc., Lowell, MA; area: 0.33 cm
2,
pore size: 0.4 mm) in NHBE differentiation media (Lonza,
Walkersville, MD) The apical media was aspirated after 24 h of
cell seeding and the cells on the polyester membrane were
maintained in media only in the basolateral compartment of the
air-liquid interface culture (ALC) [16,17]. On day 8 of ALC, the
integrity of the cell layers on the membrane was assessed by light
contrast microscope and by transepithelial electrical resistance
(TEER) [18]. After equilibration of the cell layers on the insert
with pre-warmed HBSS buffer (10 mM HEPES, 25 mM D-
glucose, pH 7.4) for 30 min (37uC, 5% CO2), TEER values were
obtained and cells with TEER values of ,600 VNcm
2 were used
for the transport and retention assays [16,17,19,20,21].
NHBE cell multilayers grown on the inserts were examined with
a Zeiss LSM 510-META laser scanning confocal microscope (Carl
Zeiss Inc., Thornwood, NJ) with a 606water immersion objective
on day 8 of ALC culture. For the confocal analyses, three different
cell-permeant dyes were prepared by dilution with HBSS buffer
10 mg/ml Hoe; 2.5 mM LysoTrackerH Green (LTG, Molecular
Probes, CA); and 1 mM MTR). After the cell multilayers were
washed with HBSS, 240 ml of dye mixture (80 ml of each dye in
HBSS) was added to the apical compartment and 600 ml of HBSS
was added to the basolateral side. After 30 min, transport of the
dyes across the cell layers was measured by placing the insert into a
two-chambered slide (Lab-TeKH; Thermo Scientific Nunc co.,
Rochester, NY) and acquiring images along the Z-axis (interval,
1 mm) in three fluorescence channels (coherent enterprise laser
(364 nm) for Hoe, Argon laser (488 nm) for LTG, and Helium
neon 1 laser (543 nm) for MTR). The distribution of probes
applied in the apical compartment of the NHBE cell multilayer
cultures was assessed in 3D reconstructions of the acquired images
of probe distribution, using MetaMorphH software (Figure 1G).
The relative distributions of MTR, Hoe, and LTG dyes across the
multilayers were assessed by imaging analyses through multiple Z-
stacks. After background subtraction, the integrated intensity of
each fluorescence channel per cell was summed in each cell layer
and divided by the total integrated intensity in all the layers to
calculate the percentage of relative distribution of the integrated
fluorescence signal of each dye associated with inner layer or the
exposed surface layer of the NHBE cell multilayer.
Visualizing probe distribution in mice lungs after IT
instillation or IV administration
The distribution of MTR and Hoe in airways and alveoli after
IT and IV injection in live mice were determined by microscopic
imaging of cryopreserved lung tissue sections and confirmed by
visual inspection followed by quantitative imaging of high
resolution tiled mosaics assembled from fluorescence images of
tissue sections (Figure 1H). For these experiments, male C57BL/6J
mice (Jackson Laboratory, Bar Harbor, ME; 8 weeks, 20–30 g)
were used and the protocol was approved by the University of
Michigan’s animal care and use committee in accordance with the
National Institutes of Health Office of Laboratory Animal Welfare
‘‘Principles of Laboratory Animal Care.’’ MTR (50 ug in 10 ul
DMSO) and Hoe (90 ul of 10 mg/ml in ddH20) were mixed so
that the final concentration of MTR and Hoe was 0.94 and
14.61 mM, respectively. Mice received either 50 ml of dye mixture
or 50 ml saline (control) via IV tail veil injection or IT instillation
[22]. For IV administration, conscious mice were briefly restrained
and for IT instillation mice were anesthetized with isoflurane gas,
and the dose was delivered to the airway via the oral route as
previously described.
In order to study the differential regional distribution of
fluorescent dyes in the lung, mice were anesthetized with
ketamine/xylazine 40 minutes after dosing. A thoracotomy was
performed and a heparinized blood sample was acquired by
cardiac puncture. The trachea was cannulated (20G luer stub)
after which the lungs were inflated with ,1 mL of a 30% sucrose-
optimal cutting temperature (OCT; Tissue-Tek, Sakura Finetek
USA, Torrance, CA USA) mixture and removed en bloc. The lungs
A Computational Approach to Site-Directed Probes
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[23].
For microscopy, coronal lung sections (7 mm) were imaged using
an epifluorescence Olympus BX-51 microscope equipped with the
standard DAPI, FITC and TRITC filter sets. A series of low-
magnification (64) left and right lung section images were
electronically captured with an Olympus DP-70 high-resolution
digital camera using Image J software (ImageJ 1.44b, National
Institutes of Health, USA; http://rsb.info.nih.gov/ij). In order to
permit comparisons of image brightness and fluorescence, images
for each lung section were acquired using the same illumination
and image acquisition settings. Mosaics of the entire lung were
tiled using PhotoshopH (version 4; Adobe Systems Inc., San Jose,
CA) and quantitative image analysis was carried out using the
integrated morphometric analysis function of MetaMorphH.
Background subtracted fluorescence intensity values over the
airways and alveoli were measured, as the integrated value of all
pixels per unit area of the manually selected airway and alveolar
tissue regions, using the images acquired with the DAPI channel.
In turn, the same airway and alveolar tissue regions were used to
measure the MTR fluorescence signal using the images acquired
with the TRITC channel.
Results
For virtual screening experiments, molecules with maximal
tissue exposure (AUC) in the airways after inhalation were
identified by using combinations of logPn and pKa as input
parameters in a multiscale, cell-based lung transport model
(Figure 2). For weak bases, lower lipophilicity and higher pKa
promoted intracellular retention and led to greater local exposure
relative to the alveoli (Figure 2A, B). The calculated airway/alveoli
exposure ratio (Figure 2C) ranged from 100 to 700 and increased
with lowered logPn (increasing hydrophilicity) and higher pKa
(greater positively charged fraction at physiological pH) Essential-
ly, cell-permeant, hydrophilic molecules harboring a fixed positive
Figure 2. Virtual screening of monobasic compounds based differential tissue distribution in the airways and alveoli. The
combinations of logPn and pKa were used as input. For simulations, the initial dose was set to 1 mg/kg for airways and alveoli. Contour lines indicate:
A) The calculated AUC (unit: mg/ml*min) in airways; B) The AUC (unit: mg/ml*min) in alveoli; C) The AUC contrast ratio of airways to alveoli; D) The
mass percentage (%) in alveoli relative to the total mass in lung; E) The mass percentage (%) in airways relative to the total mass in lung; F) The mass
ratio of alveoli to airway. Matlab scripts used to generate plots A–C (Text S1) and D–F (Text S2) are included in the supplementary materials.
doi:10.1371/journal.pcbi.1002378.g002
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of the upper airway relative to the alveoli, following IT
administration.
To probe the role of the route of administration, simulations
were also performed by independently varying logPn and pKa to
calculate the mass deposition pattern in the airways and alveoli
under steady state conditions after IV administration (Figure 2D–
F). In this manner we established the relationship between the
physicochemical properties of small molecules and absolute and
relative mass distribution in the airways (Figure 2D) and alveoli
(Figure 2E). Following IV administration, the majority of the mass
was deposited in the alveoli irrespective of the physicochemical
properties of the molecules (Figure 2F); the airways held less than
20% of total drug mass in the lungs. Compounds with low logPn
and high pKa tended to exhibit the largest airway to alveoli mass
ratios, which paralleled the results obtained after IT administra-
tion.
In order to validate the results of these virtual screening
experiments, two fluorescent bioimaging probes, MTR and Hoe,
were selected for more detailed analysis. MTR is a cell-permeant,
hydrophilic cation, and Hoe is a cell permeant, hydrophobic weak
base. Based on the screening results (Figure 3) and more detailed
simulations (Figure 3), the concentration profiles of these two
fluorescent molecules in the airways and alveoli were markedly
different after IT (Figure 3 A, B) and more similar after IV
(Figure 3 C, D) administration. When given IT, the predicted
MTR concentration, 40 to 60 min after administration, was nearly
10-fold higher in the airways than in the alveoli (Figure 3A).
Conversely, the predicted concentration of Hoe in the airways was
two-fold higher in alveoli than in airway (Figure 3B). When given
IV, the predicted concentration of MTR in the airways was almost
the same as that in alveoli (Figure 3C). However, the predicted
concentration of Hoe in the airways was higher in alveoli
(Figure 3D). Thus, MTR should be retained in the airways
specifically after IT administration, whereas Hoe should not be
retained in airways relative to alveoli regardless of the route of
administration.
Next, cell based assays were used to establish the intracellular
retention of MTR and Hoe at a site of absorption. For this
purpose, a transwell insert system with micro-fabricated pores was
constructed. After seeding MDCK epithelial cells on the patterned
pore arrays and adding hydrophobic fluorescent compounds in the
basolateral side of cell monolayer, the time course dye uptake in
the cells sitting above the pores and the kinetics of lateral transport
from the cells lying on top of the pore to the neighboring cells was
visualized by fluorescence microscopy.
Three hours after the addition of Hoe to the basolateral
compartment, only cells that were within close vicinity of pores
were stained, indicating that the cells formed a tight seal with the
pores such that each pore fed almost exclusively into cells that
were in immediate contact with the pores (Figure 4). Monitoring of
the cell-to-cell diffusion of Hoe over time, indicated that the pores
served as point sources of sustained dye supply to the adjacent cells
(Figure 4A–D) and for cells grown on membranes with pores
spaced by 80 mm (Figure 4C) or 160 mm (Figure 4D), each pore
could be considered as the single point source of dye molecules.
Quantitative image analysis revealed that the rate of staining
rapidly decreased as the distance of the cells from the pores
Figure 3. Simulations of local pharmacokinetics of MTR and Hoe after IV an IT administration. A) The simulated tissue concentration in
airways (dash line) and alveoli (solid line) of MTR administered by IT instillation (Matlab script used to generate this plot is included as Text S3 in the
supplementary materials); B) The simulated tissue concentration in airways (dash line) and alveoli (solid line) of Hoe administered by IT instillation
(Matlab script used to generate this plot is included as Text S4 in the supplementary materials); C) The simulated tissue concentration in airways
(dash line) and alveoli (solid line) of MTR administered by IV injection (Matlab script used to generate this plot is included as Text S5 in the
supplementary materials); D) The simulated tissue concentration in airways (dash line) and alveoli (solid line) of Hoe administered by IV injection
(Matlab script used to generate this plot is included as Text S6 in the supplementary materials).
doi:10.1371/journal.pcbi.1002378.g003
A Computational Approach to Site-Directed Probes
PLoS Computational Biology | www.ploscompbiol.org 6 February 2012 | Volume 8 | Issue 2 | e1002378increased (Figure 4E, F). Remarkably, only cells in the vicinity of
each pore were labeled.
As controls, cells were stained with Hoe plus BCECF-AM from
the basolateral compartment (Figure 4G–I). BCECF-AM is a
nonfluorescent cell-permeant ester, which generates a cell-
impermeant, fluorescent molecule upon intracellular hydrolysis.
While the extent of Hoe diffusion was dependent on the distance
from the pores (Figure 4G), the green fluorescence of the
hydrophillic ester hydrolysis product (BCECF) was exclusively
restricted to the first layer of cells that were in direct contact with
pores (Figure 4H, I).
Similar to the Hoe staining pattern, MTR also exhibited a
highly constrained diffusion pattern with most of the staining
restricted to the vicinity of each pore (Figure 5). After two-hours of
staining from the basolateral compartment with both Hoe
(Figure 5A) and MTR (Figure 5B), only cells within 60 microns
of the pore being stained with both probes (Figure 5C). The
normalized fluorescence intensity of MTR and Hoe were similar
in the first and second layers of cells, but MTR showed higher
penetration into the third layer (Figure 5D).
In the transversal direction, the absorption and retention of
MTR and Hoe across multiple layers of cells was also assessed in
primary NHBE cells differentiated as multilayers in ALC
(Figure 6). For the experiments, MTR and Hoe were simulta-
neously added in the apical side of the cells and intracellular
accumulation was assessed using 3D reconstructions of the cell
multilayers (Figure 6). As a positive control, LTG was also
included in the apical HBSS buffer. Thirty minutes after the
addition of probes to the apical compartment, both MTR and
Hoe staining were constrained to the first, outer surface layer of
cells (Figure 6, left). The cells beneath the surface layer of cells
were stained with LTG (Figure 6, right), indicating that the limited
penetration of both MTR and Hoe. Different transport patterns of
MTR, Hoe and LTG across the cell multilayers were verified by
image quantitation using MetaMorphH software in the multiple Z-
stack images of NHBE cell multilayers. Approximately
96%62.76% of MTR or 96%62.48% Hoe of the dye was
retained in the surface cell layer whereas 50%615.62% of LTG
fluorescence was associated with the surface cell layer. Tukey’s
multiple comparison test following ANOVA (one-way analysis of
variance) test showed statistically significant difference between
MTR and LTG (p-value,0.0001) and also between Hoe and
LTG (p-value,0.0001), but not between MTR and Hoe with p-
value larger than 0.05 (a=0.05).
As an ultimate test of the results of in silico virtual screening
experiments, mice were administered a mixture of MTR and Hoe
by either IV tail vein or IT instillation and the distribution of the
molecules in the lungs was assessed by fluorescent microscopy
(Figure 7). Hoe distributed throughout the lungs regardless of
route of administration (Figure 7A, B) with fluorescence in both
alveoli and airways (Figure 7C, D)). Following IV administration,
MTR also distributed throughout the lung in both airways and
alveoli (Figure 7E). Conversely, IT administered MTR resulted in
highly uneven fluorescence distribution (Figure 7F). Most
importantly, the airway regions showed comparable MTR
fluorescence in airway vs. alveoli after IV (Figure 7G) but higher
MTR fluorescence intensity in airways compared with the alveoli
following IT delivery (Figure 7H).
To confirm these observations quantitative image analysis was
performed to compute background subtracted integrated intensity
of alveolar and airway regions, to quantify the relative, differential
fluorescence intensity distribution of Hoe and MTR in airway and
Figure 4. Probing the intracellular retention of Hoe along the plane of a cell monolayer. For the experiments, Hoe was added to the
basolateral compartment and incubated for 3 hrs, with cell monolayers sitting on top of patterned pore arrays. Red spots indicate the location of
pores; Scale bar: 80 mm. Cells were imaged using the DAPI channel of an epifluorescence microscope. A)5 65 array of 3 mm pores with 20 mm
spacing; B)3 63 array of 3 mm pores with 40 mm spacing; C)3 63 array of 3 mm pores with 80 mm spacing; D)3 63 array of 3 mm pore array with
160 mm spacing; E) Fluorescent images of a cell monolayer incubated for 3 hours in the presence of Hoe in the basolateral compartment; F)
corresponding measurements of fluorescence intensity of cells in A), showing the average fluorescence of each nucleus normalized by the average
fluorescence of the nucleus closest to the pore at the 3 hr time point, and plotted as mean 6 s.d. (n=6). G) Fluorescence image of cell monolayer on
a3 63 array of 3 mm pores with 40 mm spacing after 2 hr incubation with Hoe and BCECF-AM in the basolateral compartment; H) FITC channel
corresponding to BCECF staining of the same cells as in; I) Image overlays of C and D.
doi:10.1371/journal.pcbi.1002378.g004
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3.27 for IT administration. For MTR and Hoechst, the mean (6
s.d.) percent airway delivery was 23.9%65.8% and 8.8%62.7%,
respectively (based on 422 region measurements from a single
lung). For IV administration, the fluorescence MTR/Hoe ratio
ranged from 0.95 to 1.45. The mean (6 s.d) percent airway
delivery for MTR and Hoe were 7.5%62.5% and 7.1%61.8%,
respectively (based on 383 region measurements from a single
lung). The images and measurements were consistent with local
intracellular retention of MTR in the airways compared with Hoe,
following IT (but not IV) instillation. These in vivo results paralleled
the in silico simulation results (Figure 3).
In order to identify the most important parameters that might
explain the differences in local retention of MTR and Hoe, a
parameter exchange analysis was performed using computational
simulations. For this purpose, individual parameters of the airway
were exchanged with those of the alveoli, one at a time, and the
simulations were rerun to calculate the exposure (AUC) of MTR
and Hoe. Based on the results of this simulation analysis (Table 1)
the volume of interstitial smooth muscle cells together with the
volume of mitochondria were the primary factors determining the
retention of MTR in the upper airways relative to alveoli.
Secondarily, the surface areas of epithelial and endothelial cell
layers were important, affecting retention in opposite directions.
Taken together, these results suggest that the mitochondrial
density per unit absorption surface area is the key histological
organization parameter responsible for the higher retention of
MTR in upper airways after IT administration.
Discussion
In traditional pharmacokinetic studies, drug distribution in the
lungs is analyzed in a homogeneous and well-stirred compartment
[13,24]. Here, we have elaborated an integrated, cell-based
approach to model local drug absorption and transport phenom-
ena, aimed at identifying cell-permeant molecules that are retained
in the cells of the upper airway upon local pulmonary
administration via the inhaled route. This integrated approach
can be exploited for bioimaging probe development or for
optimizing the local concentration of pulmonary medications
[25,26].
Locally acting, inhaled medications are of considerable interest
for treating various pulmonary ailments, including asthma,
chronic obstructive pulmonary disease (COPD) and pulmonary
Figure 5. Probing the intracellular retention of MTR along the plane of a cell monolayer. Cell monolayers on pore arrays were incubated
for 2 hr with Hoe and MTR in the basolateral compartment. White spots indicate the location of pores; Scale bar: 20 mm. A) Fluorescent image
acquired with the DAPI channel showing Hoe diffusing on a cell monolayer sitting on top of a single pore of a 363 array of 3 mm pores with 160 mm
spacing; B) Same field as in A, visualized with the TRITC channel to show the staining of MTR; C) Overlay of A and B showing the overlapping Hoe
(blue) and MTR (red) staining patterns. D) Plots of the fluorescence intensity of Hoe and MTR, separated by 0, 1, 2 or 3 layers of cells from a pore, and
normalized by the fluorescence intensity of the cell closest to the pore; asterisk indicates a statistically significant difference using Student’s T-test;
p,0.05; n=6).
doi:10.1371/journal.pcbi.1002378.g005
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medications include targeted drug delivery, rapid onset of action,
low systemic exposure with a resultant reduction in systemic side
effects [29,30]. Nevertheless, measuring local drug concentrations
in the lungs is challenging. Previously, regional differences in local
lung exposure have received little attention in the context of small
molecule targeting and delivery. Inhaled drug development efforts
ignore the possibility that local differences in drug exposure could
influence regional differences in drug transport properties that are
associated with structural and functional characteristics of the
airways and alveoli [31,32,33]. Accordingly, the approach
presented here is significant because it furthers our understanding
of how inhaled drug molecules and bioimaging probes behave
after local administration to the lungs. These findings have
important implications in pulmonary drug development.
Our simulations and experiments indicate that route of
administration, histological organization and circulatory parame-
ters can affect the retention and distribution of different molecular
agents in various regions of the lung based on the lipophilicity and
ionization properties of molecules, and as such, may be of pivotal
importance for the optimization of drug targeting [25,26].
Specifically, we considered two major and clearly distinguishable
regions of the lungs: the airways and the alveoli, which are
histologically and physiologically distinct. Extensive studies have
demonstrated that the regional lung deposition of drugs is largely
dependent on the aerodynamic particle size generated by delivery
devices [28,31,34,35]. Here, we introduce the concept that other
parameters (e.g., the chemical properties of molecules) may be as
important for predicting the behavior of pulmonary delivered of
drugs. This is evidenced from our simulations which indicated
that, after absorption into the blood, the majority of drug mass
(.80% of total mass in lungs) is predicted to accumulate in the
alveoli because of its larger volume and higher lipid content and
compounds with high lipophilicity and low pKa will accumulate to
even a greater extent in the alveoli. Although inhaled drug
targeting leads to most of the drug mass deposited in the upper
airways, without significant intracellular retention, the molecules
can be rapidly absorbed and circulate back to the lung to
accumulate in the alveoli. In theory, only molecules that are
retained in the cells of the upper airways at the local site of
administration can be effectively targeted to the upper airways.
To study the transport properties of small molecules in airways
and in alveoli, we conducted simulations concentrated on charac-
terizing the behavior of two fluorescent compounds, MTR or Hoe,
because they exhibited large differences in simulated transport
behaviors.Inaddition,twoinvitrocellbased assaysweredevelopedto
test the local cellular uptake and retention properties of small
molecules: 1) primary NHBE cell cultures comprised of cell
multilayers differentiated on transwell insets in the presence of an
air-liquid interface; and 2) MDCK cell monolayer cultures on
microfabricted pore arrays to establish the lateral cell-to-cell
transport kinetics of small molecules, along the plane of the cell
monolayer. In the case of Hoe and MTR, both in vitro assays
confirmed thatthe probesweretakenupandlargelyretainedbycells
in the immediate vicinity of site of absorption and that the extent of
diffusion followed a dye concentration gradient from the pores. Our
in vitro findings indicated that the lateral cell-to-cell diffusion of MTR
and Hoe was highly constrained. These in vitro results confirmed that
both Hoe and MTR were retained intracellularly at a significant
level in the presence of a transcellular concentration gradient both in
the apical-to-basolateral and lateral directions. These results were
also informative in terms of the time scale of intracellular
accumulation and the relative labeling intensity afforded by these
two fluorescent probes in the presence of a transcellular gradient.
However, the in vitro assays did not reveal a major difference in the
local retention of MTR and Hoe. Based on this observation, the
behavior of these probes in these in vitro assays appeared most
consistent with the predicted behavior of the probes in the alveoli.
Nevertheless, the results of in vivo studies closely paralleled those
obtained in silico, in that MTR was retained in airways upon local
IT administration while Hoe distributed in both airways and
alveoli irrespective of the route of administration. Although in vitro
Figure 6. Fluorescent confocal images of NHBE cell multilayers on the porous membrane with Z-stacks. Cell multilayers were stained
with MTR, Hoe and LTG. Each compartment (membrane inserts (bottom), inner cell layers, surface cell layer, and apical compartment (top)) through z-
axis were indicated with the red arrows in x–z planes while cell nuclei and cytoplasm in x–y planes. The panel to the left shows an x, y cross section
through the apical surface layer of the cell multilayer. The panel to the right shows an x, y cross section through the inner cell layer of the cell
multilayer. Scale bar: 20 mm.
doi:10.1371/journal.pcbi.1002378.g006
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PLoS Computational Biology | www.ploscompbiol.org 9 February 2012 | Volume 8 | Issue 2 | e1002378Figure 7. Tiled fluorescent micrographs of coronal cryosections obtained from the left lungs of mice. Mice received either an IV (A, C, E,
G) or IT (B, D, F, H) dose of a mixture ofHoe and MTR. A) DAPIchannel fluorescence image showing Hoe distribution following IV administration; B)D A P I
channel fluorescence image showing Hoe distribution following IT administration; C) High magnification view of the boxed region in A; D) High
magnification view ofthe boxed regionin B; E) TRITC channel fluorescenceimage showing MTR distribution followingIV administration;F) TRITCchannel
fluorescence image showing MTR distribution following IT administration; G) High magnification view of the boxed region in E; H) High magnification
view of the boxed region in F. Scale bar=1 mm. Asterisks mark the cross-sections of the airways, apparent as ellipsoids at high magnification.
doi:10.1371/journal.pcbi.1002378.g007
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of the probes, the in silico model is a better representation of the
three-dimensional organization and physiological parameters of the
in vivo situation. Parameter sensitivity analysis indicates that
mitochondrial uptake of hydrophilic cations, in relation to the
surface area over which absorption occurs, is the critical histological
component responsible for high exposure of MTR when given via
IT instillation. This is because as MTR traverses from the lumen of
the airway into the interstitium, it is rapidly taken up into the
mitochondria, driven by the high negative membrane potential of
the mitochondrial inner membrane. Conversely, release of MTR
from the mitochondria out into the circulation is very slow because
the membrane potential slows its release. In the case of alveoli, the
alveolar epithelial cells have much higher apical and basolateral
plasma membrane surface areas relative to the mitochondrial
membrane surface area. The higher cell surface areas facilitate mass
transport of MTR across the cells and into the circulation, which
reduces MTR accumulation in mitochondria.
In contrast to MTR, Hoe is a lipophilic weakly basic compound
with a pKa of 7.5. Therefore, at physiological pH, half of the
Hoechst molecules exist in a highly membrane-permeant, neutral
form. Transmembrane diffusion of the neutral form of Hoe is
orders of magnitude faster than that of a cationic form. So there is
no significant accumulation or retention of Hoe in either the
airways or the alveoli. When administered by IV injection, the
direction of distribution is from blood to the tissue. The
distribution between blood and tissue is mostly a function of the
partitioning or binding of molecules from the circulation to the
tissue, which is dependent on the cell density of the tissue, the
membrane content of the tissue, and the affinity of the probes for
membranes and intracellular components in the tissue. Thus, after
IV administration, both Hoe and MTR tended to partition more
into alveoli than into the airways.
In conclusion, we have elaborated an integrated in silico-to-in
vitro-to-in vivo modeling approach which has applicability toward
the optimization of site-specific targeting of locally-administered
molecules. In the process, we have found that MTR is a candidate
fiduciary marker for local drug deposition and absorption patterns
in the airways. Due to the compartmental nature of the lungs,
computational simulations can be linked to upstream process, such
as pulmonary particle deposition, dissolution and mucus clear-
ance, as well as to downstream processes that can be captured by
pharmacodynamic models [36,37,38]. With additional effort this
approach can be expanded to include macromolecules, acidic,
zwitterionic molecules as well as molecules possessing multiple
ionization sites, to further development of probes of lung structure
and function [39,40].
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